Lysophosphatidic acid signaling: how a small lipid does big things

被引:63
作者
Luquain, C
Sciorra, VA
Morris, AJ [1 ]
机构
[1] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27699 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27699 USA
[3] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0968-0004(03)00139-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lysophosphatidic acid (LPA) promotes growth, differentiation, survival and motility in many different cell types. LPA has therefore been suggested to play a central role in a broad range of physiological and pathophysiological processes, including vascular and neuronal function and cancer. Three closely related G-protein-coupled cell-surface receptors mediate some of these effects, but assigning specific functions to particular receptor subtypes has been challenging and several lines of evidence indicate that other LPA signaling mechanisms might exist. Although the signaling actions of LPA have been studied widely, much less is known about how LPA is generated and released into the extracellular space, and how its signaling actions are terminated. Newly identified enzymes that generate and inactivate LPA have novel roles in cancer progression and early development, and a recent study indicates that LPA might regulate nuclear gene transcription directly. These findings provide novel insights into mechanisms involved in the synthesis, actions and inactivation of LPA, and the proteins involved provide new targets that can be exploited to manipulate LPA signaling at both cellular and organismal levels.
引用
收藏
页码:377 / 383
页数:7
相关论文
共 49 条
[1]   Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid [J].
An, SZ ;
Dickens, MA ;
Bleu, T ;
Hallmark, OG ;
Goetzl, EJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 231 (03) :619-622
[2]   Serum lysophosphatidic acid is produced through diverse phospholipase pathways [J].
Aoki, J ;
Taira, A ;
Takanezawa, Y ;
Kishi, Y ;
Hama, K ;
Kishimoto, T ;
Mizuno, K ;
Saku, K ;
Taguchi, R ;
Arai, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) :48737-48744
[3]   Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid [J].
Bandoh, K ;
Aoki, J ;
Hosono, H ;
Kobayashi, S ;
Kobayashi, T ;
Murakami-Murofushi, K ;
Tsujimoto, M ;
Arai, H ;
Inoue, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (39) :27776-27785
[4]   BIOCHEMICAL-CHARACTERIZATION OF HUMAN PC-1, AN ENZYME POSSESSING ALKALINE PHOSPHODIESTERASE-I AND NUCLEOTIDE PYROPHOSPHATASE ACTIVITIES [J].
BELLI, SI ;
GODING, JW .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 226 (02) :433-443
[5]   The mechanisms of action of PPARs [J].
Berger, J ;
Moller, DE .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :409-435
[6]   Nucleotide pyrophosphatases/phosphodiesterases on the move [J].
Bollen, M ;
Gijsbers, R ;
Ceulemans, H ;
Stalmans, W ;
Stefan, C .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 35 (06) :393-432
[7]   Mammalian lipid phosphate phosphohydrolases [J].
Brindley, DN ;
Waggoner, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) :24281-24284
[8]   Requirement for the IpA1 lysophosphatidic acid receptor gene in normal suckling behavior [J].
Contos, JJA ;
Fukushima, N ;
Weiner, JA ;
Kaushal, D ;
Chun, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (24) :13384-13389
[9]   Characterization of lpa2 (Edg4) and lpa1/lpa2 (Edg2/Edg4) lysophosphatidic acid receptor knockout mice:: Signaling deficits without obvious phenotypic abnormality attributable to lpa2 [J].
Contos, JJA ;
Ishii, I ;
Fukushima, N ;
Kingsbury, MA ;
Ye, XQ ;
Kawamura, S ;
Brown, JH ;
Chun, J .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (19) :6921-6929
[10]  
Eder AM, 2000, CLIN CANCER RES, V6, P2482